Grinta, a Fintech-enabled B2B tech platform with investors from Silicon Valley’s Endeavor Catalyst and 500 Global, secured $8 million in SEED under the co-leadership of Raed Ventures and Nclude.
By enabling independent pharmacies to modernise the pharmaceutical supply chain, Grinta is a managed marketplace. To establish a data-driven, reliable, and effective pharmaceutical supply chain, Grinta is working with all value chain participants, including producers, distributors, wholesalers, and pharmacies. Grinta’s full-stack tech platform will be scaled, the team will be expanded, and growth across the Egyptian market will be accelerated thanks to the investment in the Fintech-enabled B2B tech platform that is digitising the pharmaceutical supply chain.